Related Experiment Video
Updated: Mar 11, 2026

Preparation of Mitochondria from Ovarian Cancer Tissues and Control Ovarian Tissues for Quantitative Proteomics Analysis
Published on: November 18, 2019
Mitochondrial metabolic vulnerabilities in high-grade serous ovarian cancer
Anjali Prasad1, Scott H Kaufmann2, Arun Kanakkanthara2
1Department of Oncology, Mayo Clinic, Rochester, MN 55905, United States of America.
Abstract:
High-grade serous ovarian cancer (HGSOC) is often programmed to rely heavily on mitochondrial metabolism, an adaptation that is linked to disease progression as well as resistance to standard treatments and immunotherapies. As such, mitochondrial metabolism has emerged as a promising therapeutic vulnerability to overcome resistance and selectively eliminate HGSOC cells. Several agents targeting mitochondrial metabolism are currently in or advancing toward clinical trials for various cancers. Additionally, multiple FDA-approved drugs have been repurposed to target this metabolism, and recent studies demonstrate their potential use in HGSOC therapy. This review describes the molecular mechanisms underlying mitochondrial metabolic rewiring in HGSOC and outlines the role of this rewiring in disease progression, immune evasion, and treatment resistance. In addition, we discuss current challenges and potential strategies to exploit this metabolic remodeling for more effective treatment of HGSOC.
Insights
High-grade serous ovarian cancer relies on mitochondrial metabolism, creating a vulnerability. Targeting this metabolism offers a promising strategy to overcome treatment resistance and eliminate cancer cells.
Area of Science:
- Oncology
- Cell Metabolism
- Cancer Therapeutics
Background:
- High-grade serous ovarian cancer (HGSOC) exhibits significant reliance on mitochondrial metabolism.
- This metabolic adaptation is associated with disease progression, therapeutic resistance, and immune evasion.
Purpose of the Study:
- To review the molecular mechanisms of mitochondrial metabolic rewiring in HGSOC.
- To outline the role of metabolic reprogramming in HGSOC progression, immune evasion, and treatment resistance.
- To discuss challenges and strategies for exploiting metabolic vulnerabilities in HGSOC therapy.
Main Methods:
- Literature review of molecular mechanisms in HGSOC metabolism.
- Analysis of the role of mitochondrial metabolism in HGSOC progression and treatment resistance.
- Discussion of current and emerging therapeutic strategies targeting mitochondrial metabolism.
Main Results:
- Mitochondrial metabolism is a key driver of HGSOC progression and resistance.
- Metabolic rewiring contributes to immune evasion in the HGSOC microenvironment.
- Several agents targeting mitochondrial metabolism are in clinical trials or repurposed for cancer therapy.
Conclusions:
- Targeting mitochondrial metabolism represents a promising therapeutic vulnerability in HGSOC.
- Exploiting metabolic remodeling could lead to more effective HGSOC treatments.
- Further research is needed to overcome challenges in translating metabolic targeting strategies into clinical practice.
Related Concept Videos
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Mitochondria
Oogenesis

